Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as of May 8, 2020. Currently, there are no specific COVID-19 therapies. Most patients depend on mechanical ventilation. Current...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Rep Med
Main Authors: Bonam, Srinivasa Reddy, Kaveri, Srini V., Sakuntabhai, Anavaj, Gilardin, Laurent, Bayry, Jagadeesh
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Perspective
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7190525/
https://ncbi.nlm.nih.gov/pubmed/32562483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares